IL2 and neoplasm: The cytotoxic ability of IL-36γ–treated neutrophils was enhanced by cytokines, such as IL-1β, IL-2, or TLR ligands, such as LPS or irradiated tumor cells (Figure 6B and Supplemental Figure 6D).